Results 211 to 220 of about 15,878,608 (386)

An evidence based immunohistochemical panel for diagnosing oral lymphoma along with a case series

Journal of Family Medicine and Primary Care
Oral lymphomas are rare and present a diagnostic challenge. Immunophenotyping is essential to decipher their biology and identify therapeutic targets.
V. M Aneesh, Karla M. Carvalho, Anita Dhupar, Anita Spadigam   +3 more
doaj   +1 more source

CHANGES IN MORPHOLOGY, PHENOLOGY, DEMOGRAPHY OF SEVERAL AVIAN SPECIES OVER 18 YEARS AT A RESTORED GRASSLAND [PDF]

In response to a changing climate and habitat loss, avian species are displaying changes in body size, migration phenology, and demography. Species have often adhered to Allen’s and Bergmann’s rules, displaying increased wing length and decreased body ...
McMahon, Ashley, Muise, Charlie, Stumpf, Katie   +2 more
core   +1 more source

Altered Biology of Adeno-associated Virus Type 2 and Human Papillomavirus during Dual Infection of Natural Host Tissue

, 2001
Craig Meyers, Samina Alam, Michael Mane, Paul L. Hermonat   +3 more
openalex   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source

Molecular biology and pathogenesis of the human T‐cell leukaemia/lymphotropic virus Type‐1 (HTLV‐1)

, 2001
Julie Johnson, Robert Harrod, Genoveffa Franchini   +2 more
openalex   +2 more sources

Zebrafish cornea formation and homeostasis reflect robustness in camera-type eye biology, regardless of its environment [PDF]

, 2022
Kaisa Ikkala, Sini Raatikainen, Frédéric Michon   +2 more
openalex   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

Molecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke, Marie Tölle, Philipp Walter, Kira Meißner, Mara Goetz, Jolanthe Kropidlowski, Andreas W. Berger, Jakob R. Izbicki, Felix Nickel, Thilo Hackert, Klaus Pantel, Harriet Wikman, Faik G. Uzunoglu   +12 more
wiley   +1 more source

Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients

Molecular Oncology, EarlyView.
We quantified and cultured circulating tumor cells (CTCs) of 62 patients with various cancer types and generated CTC‐derived tumoroid models from two salivary gland cancer patients. Cellular liquid biopsy‐derived information enabled molecular genetic assessment of systemic disease heterogeneity and functional testing for therapy selection in both ...
Nataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, Andrea Coluccio, Martin Hoffmann, Giancarlo Feliciello, Adithi Ravikumar Varadarajan, Xin Lu, Kathrin Weidele, Catherine Botteron, Silvia Materna–Reichelt, Felix Keil, Katja Evert, Florian Weber, Thomas Schamberger, Michael Althammer, Jirka Grosse, Dirk Hellwig, Christian Schulz, Stephan Seitz, Peter Ugocsai, Anke Schlenska‐Lange, Roman Mayr, Ulrich Kaiser, Wolfgang Dietmaier, Bernhard Polzer, Jens Warfsmann, Kamran Honarnejad, Tobias Pukrop, Daniel Heudobler, Christoph A. Klein, Christian Werno   +31 more
wiley   +1 more source

Targeting rapid TKI‐induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia

Molecular Oncology, EarlyView.
Adaptive ERK reactivation hinders FLT3 tyrosine kinase inhibitor (TKI) treatment in FLT3/ITD acute myeloid leukemia. Here, we report that FLT3 TKI treatment rapidly induces AXL expression and upregulation that is temporally associated with the adaptive ERK reactivation.
Tessa S. Seale, Li Li, J. Kyle Bruner, Melody Chou, Bao Nguyen, Jaesung Seo, Ruiqi Zhu, Mark J. Levis, Christine A. Pratilas, Donald Small   +9 more
wiley   +1 more source

BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types [PDF]

, 2014
Eleanor Howe, Aline de Souza, David L. Lahr, Simon Chatwin, Philip Montgomery, Benjamin Alexander, Ðắc-Trung Nguyễn, Y. Cruz, Derek Stonich, Gil Walzer, Jordan Rose, Serge Picard, Z. Liu, Jerome Rose, Xia Xiang, Jacob K. Asiedu, D. Durkin, John E. Levine, Jeremy J. Yang, Stephan C. Schürer, John Braisted, Noel Southall, Mark R. Southern, Thomas D.Y. Chung, Steve Brudz, Cordelle Tanega, Stuart L. Schreiber, J.A. Bittker, Rajarshi Guha, P.A. Clemons   +29 more
openalex   +1 more source